Polymer Syringes - Stevanato Group
This webinar focuses on primary packaging, where the drug product will be in direct contact with the container closure system for a substantial period of time before reaching the patients
Home - Managing Complexity, Delivering Value - Stevanato Group > Products & Capabilities - Stevanato Group > Drug containment solutions: Pharmaceutical glass containers - Stevanato Group > Pre-sterilized syringe systems: Alba, Nexa, Fina syringes systems - Stevanato Group > Polymer Syringes - Stevanato Group
page-wrapper

An unmatched offering on polymer syringes

Improving patients’ life, always! The state-of-the-art Nexa FlexTM pre-sterilized polymer syringe is our new addition, widening even further our syringes portfolio. Available both in COP (Cyclic Olefin Polymer) and COC (Cyclic Olefin Copolymer) material, customers can now benefit from an unmatched offering on both glass and polymer solutions.

Nexa Flex: Nexa® performance level now available also for your Polymer Syringes

Extremely versatile, with outstanding cosmetic quality, a high degree of break resistance, and glass-like transparency, Nexa Flex is the perfect answer when looking for polymer syringes.

Available as 1mL long*, Nexa Flex is delivered in EZ-fill® nest & tub configuration and EO-sterilized, making it compatible with the most established filling lines.

Moreover, its tungsten-free molding polymer process guarantees full compatibility with highly sensitive drugs and its optimized silicone-oil distribution along the barrel provides enhanced gliding performance and low particle profile. The molded luer lock ensures extremely strong hanging whilst production in the injection molding process grants precise dimensions, thus delivering a best-in-class solution.

* Other formats available upon request.

Features at a glance:

  • Available both in COP and COC materials to suit any requirement
  • Excellent mechanical properties
  • Superior cosmetic quality to maximize efficiency along the entire customer process.
  • Luer lock as an integrated part
  • Screw cap closure*
  • Proven siliconization process

 

*Tamper-evident closure available.

Benefit from Stevanato Group renowned market expertise together with Transcoject accomplished technological know-how on polymer containers.

Leveraging on Transcoject technology transfer and established capacity, we will initially grant our customers the delivery of samples and production batches of a solution already validated within the market. Production capacity at Stevanato Group premises is expected to be ready in 2025.

Preferred market choice:
236 Monoclonal Antibodies

Biologics

199A Biologic Molecule

mRNA applications

199 Chemical Molecule

Hyaluronic acid and other highly viscous drugs 

436A Polymer Syringe 2

Intravenous applications 

This extremely versatile solution is just the perfect answer to a broad range of therapeutic areas and applications

Interested in Polymer Syringes?
Submit your request